Stay updated on ZYN002 Long-Term Safety in Children with FXS Clinical Trial
Sign up to get notified when there's something new on the ZYN002 Long-Term Safety in Children with FXS Clinical Trial page.

Latest updates to the ZYN002 Long-Term Safety in Children with FXS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has been updated to reflect a new open-label extension study for ZYN002 in children and adolescents with Fragile X Syndrome, with changes in the study's duration, number of locations, and age range of participants.SummaryDifference5%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check43 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.3%
- Check86 days agoChange DetectedThe study's location count has decreased from 26 to 25, with the latest update posted on December 17, 2024.SummaryDifference1%
Stay in the know with updates to ZYN002 Long-Term Safety in Children with FXS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZYN002 Long-Term Safety in Children with FXS Clinical Trial page.